<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://www.med-guidelines.org.uk/index.php?action=history&amp;feed=atom&amp;title=Non_Steroidal_Anti-Inflammatory_Drug</id>
	<title>Non Steroidal Anti-Inflammatory Drug - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.med-guidelines.org.uk/index.php?action=history&amp;feed=atom&amp;title=Non_Steroidal_Anti-Inflammatory_Drug"/>
	<link rel="alternate" type="text/html" href="https://www.med-guidelines.org.uk/index.php?title=Non_Steroidal_Anti-Inflammatory_Drug&amp;action=history"/>
	<updated>2026-05-04T19:03:18Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.34.1</generator>
	<entry>
		<id>https://www.med-guidelines.org.uk/index.php?title=Non_Steroidal_Anti-Inflammatory_Drug&amp;diff=2123&amp;oldid=prev</id>
		<title>Frances.Sarkari@anthonynolan.org: /* Acceptability at CT / Work-Up */</title>
		<link rel="alternate" type="text/html" href="https://www.med-guidelines.org.uk/index.php?title=Non_Steroidal_Anti-Inflammatory_Drug&amp;diff=2123&amp;oldid=prev"/>
		<updated>2025-03-04T12:16:33Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Acceptability at CT / Work-Up&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 12:16, 4 March 2025&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l2&quot; &gt;Line 2:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 2:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;QUALIFIED&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;QUALIFIED&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Acceptability at &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;CT &lt;/del&gt;/ Work-Up==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Acceptability at &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;VT &lt;/ins&gt;/ Work-Up==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;QUALIFIED&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;QUALIFIED&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;!-- diff cache key localdb-mw_:diff::1.12:old-1308:rev-2123 --&gt;
&lt;/table&gt;</summary>
		<author><name>Frances.Sarkari@anthonynolan.org</name></author>
		
	</entry>
	<entry>
		<id>https://www.med-guidelines.org.uk/index.php?title=Non_Steroidal_Anti-Inflammatory_Drug&amp;diff=1308&amp;oldid=prev</id>
		<title>PaulM: /* Guidance */</title>
		<link rel="alternate" type="text/html" href="https://www.med-guidelines.org.uk/index.php?title=Non_Steroidal_Anti-Inflammatory_Drug&amp;diff=1308&amp;oldid=prev"/>
		<updated>2016-06-01T16:51:25Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Guidance&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 16:51, 1 June 2016&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l18&quot; &gt;Line 18:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 18:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Donors should not use aspirin for seven days prior to donation.  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Donors should not use aspirin for seven days prior to donation.  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Other &lt;/del&gt;NSAIDs should be stopped 24 hours prior to harvest.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;NSAIDs should be stopped 24 hours prior to harvest.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;NSAIDs may be recommenced immediately post-harvest. However, aspirin should be avoided for three days post bone-marrow harvest, and for one week if a donor has a documented thrombocytopenia (&amp;lt;80 x10^9) after PBSC harvest.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;NSAIDs may be recommenced immediately post-harvest. However, aspirin should be avoided for three days post bone-marrow harvest, and for one week if a donor has a documented thrombocytopenia (&amp;lt;80 x10^9) after PBSC harvest.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;!-- diff cache key localdb-mw_:diff::1.12:old-1032:rev-1308 --&gt;
&lt;/table&gt;</summary>
		<author><name>PaulM</name></author>
		
	</entry>
	<entry>
		<id>https://www.med-guidelines.org.uk/index.php?title=Non_Steroidal_Anti-Inflammatory_Drug&amp;diff=1032&amp;oldid=prev</id>
		<title>Dr Robert Lown: /* Guidance */ updated guidance for NSAIDs prior to harvest</title>
		<link rel="alternate" type="text/html" href="https://www.med-guidelines.org.uk/index.php?title=Non_Steroidal_Anti-Inflammatory_Drug&amp;diff=1032&amp;oldid=prev"/>
		<updated>2012-08-09T13:15:39Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Guidance: &lt;/span&gt; updated guidance for NSAIDs prior to harvest&lt;/span&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 13:15, 9 August 2012&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l18&quot; &gt;Line 18:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 18:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Donors should not use aspirin for seven days prior to donation.  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Donors should not use aspirin for seven days prior to donation.  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Other NSAIDs should be stopped &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;three days &lt;/del&gt;prior to &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;donation or commencement of G-CSF, whichever is earlier&lt;/del&gt;.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Other NSAIDs should be stopped &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;24 hours &lt;/ins&gt;prior to &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;harvest&lt;/ins&gt;.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;NSAIDs may be recommenced immediately post-harvest. However, aspirin should be avoided for three days post bone-marrow harvest, and for one week if a donor has a documented thrombocytopenia (&amp;lt;80 x10^9) after PBSC harvest.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;NSAIDs may be recommenced immediately post-harvest. However, aspirin should be avoided for three days post bone-marrow harvest, and for one week if a donor has a documented thrombocytopenia (&amp;lt;80 x10^9) after PBSC harvest.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;!-- diff cache key localdb-mw_:diff::1.12:old-840:rev-1032 --&gt;
&lt;/table&gt;</summary>
		<author><name>Dr Robert Lown</name></author>
		
	</entry>
	<entry>
		<id>https://www.med-guidelines.org.uk/index.php?title=Non_Steroidal_Anti-Inflammatory_Drug&amp;diff=840&amp;oldid=prev</id>
		<title>Dr Robert Lown: Protected &quot;Non Steroidal Anti-Inflammatory Drug&quot; (‎[edit=sysop] (indefinite) ‎[move=sysop] (indefinite))</title>
		<link rel="alternate" type="text/html" href="https://www.med-guidelines.org.uk/index.php?title=Non_Steroidal_Anti-Inflammatory_Drug&amp;diff=840&amp;oldid=prev"/>
		<updated>2012-06-19T13:07:34Z</updated>

		<summary type="html">&lt;p&gt;Protected &amp;quot;&lt;a href=&quot;/Non_Steroidal_Anti-Inflammatory_Drug&quot; title=&quot;Non Steroidal Anti-Inflammatory Drug&quot;&gt;Non Steroidal Anti-Inflammatory Drug&lt;/a&gt;&amp;quot; (‎[edit=sysop] (indefinite) ‎[move=sysop] (indefinite))&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 13:07, 19 June 2012&lt;/td&gt;
				&lt;/tr&gt;
&lt;!-- diff cache key localdb-mw_:diff::1.12:old-382:rev-840 --&gt;
&lt;/table&gt;</summary>
		<author><name>Dr Robert Lown</name></author>
		
	</entry>
	<entry>
		<id>https://www.med-guidelines.org.uk/index.php?title=Non_Steroidal_Anti-Inflammatory_Drug&amp;diff=382&amp;oldid=prev</id>
		<title>Dr Robert Lown: Page created</title>
		<link rel="alternate" type="text/html" href="https://www.med-guidelines.org.uk/index.php?title=Non_Steroidal_Anti-Inflammatory_Drug&amp;diff=382&amp;oldid=prev"/>
		<updated>2012-06-14T10:28:10Z</updated>

		<summary type="html">&lt;p&gt;Page created&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Acceptability at Recruitment==&lt;br /&gt;
QUALIFIED&lt;br /&gt;
&lt;br /&gt;
==Acceptability at CT / Work-Up==&lt;br /&gt;
QUALIFIED&lt;br /&gt;
&lt;br /&gt;
==Individual at Risk==&lt;br /&gt;
Donor&lt;br /&gt;
&lt;br /&gt;
==Explanation of Condition==&lt;br /&gt;
Type of drug used as a pain-killer. &lt;br /&gt;
&lt;br /&gt;
See also [http://en.wikipedia.org/wiki/Non-steroidal_anti-inflammatory_drug NSAID]&lt;br /&gt;
&lt;br /&gt;
==Guidance==&lt;br /&gt;
Establish reason for taking, and check this is not a cause for exclusion. &lt;br /&gt;
&lt;br /&gt;
Donors should not use aspirin for seven days prior to donation. &lt;br /&gt;
&lt;br /&gt;
Other NSAIDs should be stopped three days prior to donation or commencement of G-CSF, whichever is earlier.&lt;br /&gt;
&lt;br /&gt;
NSAIDs may be recommenced immediately post-harvest. However, aspirin should be avoided for three days post bone-marrow harvest, and for one week if a donor has a documented thrombocytopenia (&amp;lt;80 x10^9) after PBSC harvest.&lt;br /&gt;
&lt;br /&gt;
==Pseudonyms or Related Conditions==&lt;br /&gt;
NSAID &lt;br /&gt;
&lt;br /&gt;
Aspirin&lt;br /&gt;
&lt;br /&gt;
Ibuprofen&lt;br /&gt;
&lt;br /&gt;
Diclofenac &lt;br /&gt;
&lt;br /&gt;
Naproxen&lt;br /&gt;
&lt;br /&gt;
Indomethacin&lt;br /&gt;
&lt;br /&gt;
Ketorolac&lt;br /&gt;
&lt;br /&gt;
Mefanamic acid&lt;br /&gt;
&lt;br /&gt;
Celecoxib&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Version==&lt;br /&gt;
Version 1, Edition 1	&lt;br /&gt;
&lt;br /&gt;
====Date of Last Update====&lt;br /&gt;
15th June 2012&lt;/div&gt;</summary>
		<author><name>Dr Robert Lown</name></author>
		
	</entry>
</feed>